Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
Fibrosis is the abnormal deposition of extracellular matrix, characterized by accumulation of collagen and other extracellular matrix components, which causes organ dysfunction and even death. Despite advances in understanding fibrosis pathology and clinical management, there is no treatment for fib...
Main Authors: | Yi Zhu, Yilu Chai, Guojin Xiao, Yufei Liu, Xiaohong Xie, Wei Xiao, Pengcheng Zhou, Wei Ma, Chuantao Zhang, Liuying Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1040350/full |
Similar Items
-
Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy
by: Yulian Liu, et al.
Published: (2024-04-01) -
Astragalus Mongholicus: A review of its anti-fibrosis properties
by: Fengying Gong, et al.
Published: (2022-09-01) -
Promoting the Development of Astragalus mongholicus Bunge Industry in Guyang County (China) Based on MaxEnt and Remote Sensing
by: Ru Zhang, et al.
Published: (2022-07-01) -
Discrimination of producing areas of Astragalus membranaceus using electronic nose and UHPLC-PDA combined with chemometrics
by: Wenlong Wei, et al.
Published: (2017-02-01) -
Biosynthetic mechanisms of isoflavone accumulation affected by different growth patterns in Astragalus mongholicus products
by: Fusheng Zhang, et al.
Published: (2022-08-01)